Shionogi & Co., Ltd. (OTCMKTS:SGIOF – Get Free Report) fell 7.1% on Friday. The stock traded as low as $16.39 and last traded at $16.39. 269 shares were traded during trading, a decline of 86% from the average daily volume of 1,856 shares. The stock had previously closed at $17.65.
Shionogi & Co., Ltd. Stock Down 7.1%
The stock has a 50 day simple moving average of $17.81 and a 200-day simple moving average of $18.76.
Shionogi & Co., Ltd. Company Profile
Shionogi & Co, Ltd. is a Japan-based pharmaceutical company engaged in the research, development, manufacture and marketing of prescription medicines. The company focuses on addressing unmet medical needs, with core expertise in infectious diseases, central nervous system disorders and pain management.
Its products and development programs include treatments for influenza and other infectious diseases, as well as antibacterial medicines for drug-resistant infections. Shionogi developed Xofluza (baloxavir marboxil), an oral influenza treatment, and cefiderocol, an antibacterial agent marketed in some regions under the Fetroja or Fetcroja names.
See Also
- Five stocks we like better than Shionogi & Co., Ltd.
- Costco Ends Its Fiscal Year on a High Note, Eyes Big Expansion
- Cracker Barrel Stock Is Rallying Again, But the Turnaround Still Has a Traffic Problem
- Oracle’s Force Majeure Notice Exposes a Bigger Problem for the AI Build-Out
- Oil May Be Stronger Than It Looks—And Diamondback Is on Sale
Receive News & Ratings for Shionogi & Co. Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shionogi & Co. Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.
